On the heels of Madison-based EnsoData announcing the completion of a $20 million Series A funding round, the company has also announced a noteworthy leadership change.
Justin Mortara, the company’s executive chairman and an investor in the business, has also been named president. Mortara is also the co-founder of Milwaukee-based Rose Biosciences, a tech-focused bio startup, and principal at Mortara Group, LLC. He also spent over 20 years at Mortara Instrument, a provider of diagnostics for cardiovascular disease, as CEO. In February 2017, Mortara Instrument was acquired by Chicago-based Hill-Rom Holdings Inc. for $330 million.
In his new role as president, Mortara will support EnsoData’s vision by preparing the company for scale in its next stage of growth. This includes expanding EnsoData’s team, advancing its commercial strategy and identifying new strategic opportunities. Prior to this role, Mortara also managed a portfolio of early-stage health care investments spanning devices, tech-enabled services and life sciences.